Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon P Gockerman

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Cancer|September 30, 2004
Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patientsShawn D Safford, R Edward Coleman, Jon P Gockerman, et al.
Surgery|December 12, 2003
Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paragangliomaShawn D Safford, R Edward Coleman, Jon P Gockerman, et al.
Clinical Lymphoma|October 15, 2003
Rituximab in lymphocyte predominance Hodgkin's disease: a case seriesValerie K Ibom, Robert G Prosnitz, Jerald Z Gong, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapyDaniel S Oh, James A Vredenburgh, David A Reardon, et al.
Anticancer Research|January 2, 2010
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.
Blood|November 4, 2006
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversificationAlicia D Volkheimer, J Brice Weinberg, Bethany E Beasley, et al.
Leukemia Research|January 9, 2008
CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constantMarc C Levesque, Dipak K Ghosh, Bethany E Beasley, et al.
Leukemia Research|October 11, 2012
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemiaTod A Morris, Carlos M DeCastro, Louis F Diehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Patricia Creel, James Turnbull, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Cancer|September 30, 2004
Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patientsShawn D Safford, R Edward Coleman, Jon P Gockerman, et al.
Surgery|December 12, 2003
Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paragangliomaShawn D Safford, R Edward Coleman, Jon P Gockerman, et al.
Clinical Lymphoma|October 15, 2003
Rituximab in lymphocyte predominance Hodgkin's disease: a case seriesValerie K Ibom, Robert G Prosnitz, Jerald Z Gong, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapyDaniel S Oh, James A Vredenburgh, David A Reardon, et al.
Anticancer Research|January 2, 2010
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.
Blood|November 4, 2006
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversificationAlicia D Volkheimer, J Brice Weinberg, Bethany E Beasley, et al.
Leukemia Research|January 9, 2008
CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constantMarc C Levesque, Dipak K Ghosh, Bethany E Beasley, et al.
Leukemia Research|October 11, 2012
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemiaTod A Morris, Carlos M DeCastro, Louis F Diehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Patricia Creel, James Turnbull, et al.
Pageof 6